On the other hand, perhaps inhibition of multiple DPPs will synergise such that less selective inhibitors, such as Val-boroPro, that inhibit all the DPP4 family will be shown to be more useful than selective inhibition in cancer therapy. The gene discussed is DPP4; the disease is cancer.